Ceryx Medical Gets Trial Approval for New Pacemaker from MHRA
Ceryx Medical has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ceryx Medical’s clinical trial authorisation application for the pilot RSA-pace study of the Cysoni-XT system for post-cardiac surgery patients.
Pacemaker | 24/07/2024 | By Aishwarya | 588
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy